Ascierto PA - Search Results

1

Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.

Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G, Castello G. Scala S, et al. Among authors: ascierto pa. Clin Cancer Res. 2005 Mar 1;11(5):1835-41. doi: 10.1158/1078-0432.CCR-04-1887. Clin Cancer Res. 2005. PMID: 15756007

2

The soluble interleukin-2 receptor as an indicator of clinical evolution in patients with ulcerative colitis.

Balzano A, Bove A, Leonardi E, Bevilacqua N, Grande G, Ascierto PA, Castello G. Balzano A, et al. Among authors: ascierto pa. Eur J Gastroenterol Hepatol. 1997 Feb;9(2):173-7. doi: 10.1097/00042737-199702000-00012. Eur J Gastroenterol Hepatol. 1997. PMID: 9058629

3

Immunological phenotype analysis of patients with Fanconi's anaemia and their family members.

Castello G, Gallo C, Napolitano M, Ascierto PA. Castello G, et al. Among authors: ascierto pa. Acta Haematol. 1998;100(1):39-43. doi: 10.1159/000040861. Acta Haematol. 1998. PMID: 9691145

4

Epiluminescence microscopy as a useful approach in the early diagnosis of cutaneous malignant melanoma.

Ascierto PA, Satriano RA, Palmieri G, Parasole R, Bosco L, Castello G. Ascierto PA, et al. Melanoma Res. 1998 Dec;8(6):529-37. doi: 10.1097/00008390-199812000-00008. Melanoma Res. 1998. PMID: 9918415

5

3-year treatment with recombinant interferon-alpha as adjuvant therapy of cutaneous malignant melanoma.

Ascierto PA, Palmieri G, Parasole R, Daponte A, Castello G. Ascierto PA, et al. Int J Mol Med. 1999 Mar;3(3):303-6. doi: 10.3892/ijmm.3.3.303. Int J Mol Med. 1999. PMID: 10028056 Clinical Trial.

6

Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.

Palmieri G, Strazzullo M, Ascierto PA, Satriano SM, Daponte A, Castello G. Palmieri G, et al. Among authors: ascierto pa. J Clin Oncol. 1999 Jan;17(1):304-11. doi: 10.1200/JCO.1999.17.1.304. J Clin Oncol. 1999. PMID: 10458247

7

Sensitivity and specificity of epiluminescence microscopy: evaluation on a sample of 2731 excised cutaneous pigmented lesions. The Melanoma Cooperative Study.

Ascierto PA, Palmieri G, Celentano E, Parasole R, Caracò C, Daponte A, Chiofalo MG, Melucci MT, Mozzillo N, Satriano RA, Castello G. Ascierto PA, et al. Br J Dermatol. 2000 May;142(5):893-8. doi: 10.1046/j.1365-2133.2000.03468.x. Br J Dermatol. 2000. PMID: 10809845

8

Low doses interferon-alpha in the treatment of high-risk cutaneous melanoma. Melanoma Cooperative Group.

Ascierto PA, Palmieri G, Strazzullo M, Daponte A, Botti G, Satriano SM, Motti ML, Mozzillo N. Ascierto PA, et al. Ann Oncol. 2000 Apr;11(4):487-90. doi: 10.1023/a:1008375418507. Ann Oncol. 2000. PMID: 10847472 Free article. No abstract available.

9

Circulating melanoma-associated markers detected by RT-PCR in patients with classic Kaposi's sarcoma.

Palmieri G, Ascierto PA, Satriano SM, Strazzullo M, Apice G, Castello G. Palmieri G, et al. Among authors: ascierto pa. Ann Oncol. 2000 May;11(5):635-6. doi: 10.1023/a:1008397020749. Ann Oncol. 2000. PMID: 10907962 Free article. No abstract available.

10

Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon.

Ascierto PA, Daponte A, Parasole R, Perrone F, Caracò C, Melucci M, Palmieri G, Napolitano M, Mozzillo N, Castello G. Ascierto PA, et al. Cancer. 2000 Oct 1;89(7):1490-4. doi: 10.1002/1097-0142(20001001)89:7<1490::aid-cncr11>3.0.co;2-v. Cancer. 2000. PMID: 11013362 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

709 results

Search Page

Filters